SOHO Insider SOHO Insider EHA 2025 Congress: Hematology Research Updates

Skip to content

In vivo CAR-T shows promise but questions remain
Dr. Nirav Shah on the next iteration in CAR-T cell therapy in blood cancer
Jean-Marie Michot, MD, discusses the phase 3 Olympia-3 study
Australia TGA approves tafasitamab combo in relapsed, refractory FL
Global trial gaps in representation complicate US drug approvals

Join SOHO

Follow Us :

Insider Podcast
Society Updates
Resources
Hem/Onc Library
- Current Issue
  - Past Issues
- Cellular Therapy
- Leukemia
  - ALL
  - AML
  - CLL
  - CML
- Lymphoma
  - ABCL
  - IBCL
  - MCL
  - TCL
- MDS
- MPN
- Multiple Myeloma
Community Oncology
- Past Sessions
Meeting News
Multimedia
- Roundtable Discussions
- Video Interviews
Subscribe

About Us

The Society of Hematologic Oncology (SOHO) was established as a non-profit corporation in 2012 with aims to promote worldwide research, education, prevention, clinical studies and optimal patient care in all aspects of hematologic malignancies and related disorders.

Join SOHO

Categories

Post-CAR-T recovery of T cell, NK cell counts predicts long-term prognosis in B-ALL

Cellular Therapy

Post-CAR-T recovery of T cell, NK cell counts predicts long-term prognosis in B-ALL

Leukemia

Post-CAR-T recovery of T cell, NK cell counts predicts long-term prognosis in B-ALL

Lymphoma

Post-CAR-T recovery of T cell, NK cell counts predicts long-term prognosis in B-ALL

Multiple Myeloma

Post-CAR-T recovery of T cell, NK cell counts predicts long-term prognosis in B-ALL

Myelodysplastic Syndromes

Post-CAR-T recovery of T cell, NK cell counts predicts long-term prognosis in B-ALL

Myeloproliferative Neoplasms

Contact Info

[email protected] 1.281.364.7387

Follow Us

May 1, 2026

Insider Podcast
Society Updates
Resources
Hem/Onc Library
- Current Issue
  - Past Issues
- Cellular Therapy
- Leukemia
  - ALL
  - AML
  - CLL
  - CML
- Lymphoma
  - ABCL
  - IBCL
  - MCL
  - TCL
- MDS
- MPN
- Multiple Myeloma
Community Oncology
- Past Sessions
Meeting News
Multimedia
- Roundtable Discussions
- Video Interviews
Subscribe

SOHO Insider Hem/Onc Library Meetings / Conferences EHA 2025

EHA 2025

News from the EHA 2025 Congress held in Milan, Italy.

Cancer detection and screening as a treatment for malignant cells with a biopsy or testing caused by carcinogens and genetics with a cancerous cell as an immunotherapy symbol as a 3D render.

EHA 2025

Post-CAR-T recovery of T cell, NK cell counts predicts long-term prognosis in B-ALL

by SOHO Insider Editors
June 15, 2025
0 Comments

pregnant woman's belly with fingers heart symbol

EHA 2025 Meetings / Conferences News

Study supports recommendation that pregnancy be avoided in women taking ponatinib

by SOHO Insider Editors
June 14, 2025
0 Comments

Molecular structure of cancer cells under microscope, realistic macro indoor part of body.

EHA 2025

Longer-term follow-up demonstrates efficacy of nemtabrutinib for refractory FL

by SOHO Insider Editors
June 14, 2025
0 Comments

EHA 2025

EHA 2025 Meetings / Conferences Myeloproliferative Neoplasms

Dr. Kuykendall from EHA 2025: ‘the research is as hot as the conference center’

by SOHO Insider Editors
June 13, 2025
0 Comments

EHA 2025

EHA 2025 News

FELIX post-hoc data reinforce obe-cel durability

by SOHO Insider Editors
June 12, 2025
0 Comments

1
2

Top Categories

Cellular Therapy

69

Leukemia

106

Lymphoma

119

Multiple Myeloma

92

Myelodysplastic Syndromes

36

Myeloproliferative Neoplasms

21

POPULAR NEWS

The Society of Hematologic Oncology (SOHO) was established as a non-profit corporation in 2012 with aims to promote worldwide research, education, prevention, clinical studies and optimal patient care in all aspects of hematologic malignancies and related disorders.

About

About Us / Editorial Board

Advertising

Contact Us

Support SOHO

Categories

FELIX post-hoc data reinforce obe-cel durability

Cellular Therapy

FELIX post-hoc data reinforce obe-cel durability

Leukemia

FELIX post-hoc data reinforce obe-cel durability

Lymphoma

FELIX post-hoc data reinforce obe-cel durability

Multiple Myeloma

FELIX post-hoc data reinforce obe-cel durability

Myelodysplastic Syndromes

FELIX post-hoc data reinforce obe-cel durability

Myeloproliferative Neoplasms

Subscribe

Recent Posts

IV therapy; CAR-T

In vivo CAR-T shows promise but questions remain

SOHO Insider podcast

Dr. Nirav Shah on the next iteration in CAR-T cell therapy in blood cancer

Phase 3 Olympia-3 study-BW

Jean-Marie Michot, MD, discusses the phase 3 Olympia-3 study

Copyright © 2026 Society of Hematologic Oncology, All rights reserved.